The simultaneous publication of 2 articles in a recent issue of the Journal (1,2) exemplified the value of activation-recovery interval (ARI) determination in understanding the electrophysiological mechanisms of Brugada syndrome. These publications also highlighted the current controversies surrounding how ARI should be measured in vivo: Nagase et al. (1) determined ARIs at the maximum positive slope of the positive T-wave (conventional approach), whereas Hayashi et al. (2) determined ARIs at the negative slope of the positive T-wave (alternative approach).
Reply
We thank Dr. Yue for his interest in our article (1) . In general, direct measurement of action potential duration (APD) in humans is very difficult and complicated. Consequently, activation recovery interval (ARI) has been used in several studies for the evaluation of APD in humans. It is still unclear, and further examination is needed to evaluate APD by the ARI method, especially in cases of a positive T-wave. Haws and Lux (2) Because the methods used in their study to validate the use of ARI were inhomogeneous and because the assessment of polarity is difficult in a complicated T-wave, it is still not clear which method is more accurate and appropriate. The limitation of the ARI method is that ARI represents spatial average and contains a far field effect. We should carefully apply and assess the ARI method for evaluation of APD in consideration of this limitation.
Yan and Antzelevitch (6) found in their experimental study that a prominent transient outward current-mediated action potential notch in epicardial cells, but not that in endocardial cells, creates a transmural voltage gradient and thus causes ST-segment elevation. Further accentuation of the notch leads to preferential prolongation of the epicardial action potential, resulting in the development of coved-type ST-segment elevation and terminal inverted T-wave (type 1 electrocardiogram [ECG]) in right precordial leads in Brugada syndrome. In our study, we also found that type 1 ECG is closely related to the prolongation of repolarization in the epicardium compared with that in the endocardium in Brugada syndrome (1) . The administration of pilsicainide predominantly affected the epicardial repolarization, and the effect of pilsicainide administration was small in the endocardial site. We cannot completely rule out the possibility that epicardial heterogeneity of the action potential causes type 1 ECG. However, these results suggest that the pathological and critical change mainly observed in epicardial cells caused typical Brugada-type ECG. 
